Arjunvasan Ambigapathy, Research Analyst, Frost & Sullivan

Frost & Sullivan Technology Innovation Award Conferred on AQTIS Medical BV for its Pioneering Ellansé™. Read the analist quotes from Mr. Arjunvasan Ambigapathy on the Frost & Sullivan website by clicking the image below. You can also read some highlights below.

Quote 1:
“Despite high popularity of hyaluronic acid fillers among television anchors and celebrities, their usage for various procedures is entirely dependant on skills of surgeon and tolerance level of the patient. Ellansé™, a poly-caprolactone (PCL)-based dermal filler introduced by AQTIS Medical has been quite successful in establishing excellent safety profile and in enabling wide cosmetic applications. AQTIS Medical has tapped the potential of PCL to create one-of-a-kind polymeric microspheres that offer optimum viscosity, desired elasticity and uniform homogeneity.” says Arjunvasan Ambigapathy, Research Analyst at Frost & Sullivan

Quote 2:
“Ellansé™ delivers immediate and sustained performance with total bioresorbability through its four variants (S, M, L and E), who’s duration of action varies from 9 months up to 4 years. An unique aspect of STAT Technology embedded in Ellansé™ is that all four variants differ solely based on strength of their initial molecular weight of PCL
molecular polymer chains, accounting to its nature of controlled bioresorption and tuneable longevity.”, he noted.

Quote 3:
He also said, “Compared to several leading dermal fillers available in the market, Ellansé™ stands distinct in its property of tunable longevity and sustained performance, which are highly favorable for customer adoption. Aesthetic surgeons who perform procedures using other dermal fillers have observed positive effects on the use of Ellansé™, recommending it for most cosmetic applications.”

Quote 4:
“At a time when huge pricing competition is prevalent among large cosmetic companies, AQTIS Medical has taken efforts to commercialize their technology in several countries in Western Europe, South America, Middle East and Africa within a short time-frame; proving their capability to innovate and attain high customer retention rate.”, concludes
Mr.Ambigapathy

 

15th February 2011 News